lopinavir 100mg and ritonavir 25 mg tablets usp film-coated tablet
macleods pharmaceuticals limited atlanta arcade, marol church road,andheri east, - lopinavir 100mg and ritonavir 25 mg tablets usp - film-coated tablet - lopinavir 100mg and ritonavir 25 mg tablets usp - ritonavir
lopinavir/ ritonavir tablets 200mg/50mg
mylan laboratories limited c/o surgilinks ltd mylan laboratories limited r&d center plot no. - lopinavir usp & ritonavir usp - tablet - lopinavir usp 200mg + ritonavir usp 50mg - antivirals for systemic use: protease inhibitors
kaletra oral solution
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
kaletra 100 mg25 mg tablets
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - lopinavir 100 mg; ritonavir 25 mg - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infections.
kaletra 200 mg50 mg tablets
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
kaletra 200 mg50 mg tablets
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
highlights of prescribing information
american health packaging - ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - ritonavir 100 mg - ritonavir tablets are indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. - when co-administering ritonavir with other protease inhibitors, see the full prescribing information for that protease inhibitor including contraindication information. - ritonavir is contraindicated in patients with known hypersensitivity (e.g., toxic epidermal necrolysis (ten) or stevens-johnson syndrome) to ritonavir or any of its ingredients. - ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening reactions. - ritonavir is contraindicated with drugs that are potent cyp3a inducers where significantly reduced lopinavir plasma concentrations may be associated with the potential for loss of virologic response and possible resistance and cross-resistance. drug class drugs within class that are contraindicated with ritonavir * clinical comments alpha 1 -ad
lopinavir and ritonavir
macleods pharmaceuticals ltd - lopinavir; ritonavir - tablet; oral - 100; 25mg
lopinavir and ritonavir tablets 100 + 25 mg
macleods pharmaceuticals limited, india - lopinavir , ritonavir - tablets - 100 + 25 mg
lopinavir 200mg and ritonavir 50 mg tablets film-coated tablet
macleods pharmaceuticals limited atlanta arcade church road andheri kurla road - lopinavir 200mg and ritonavir 50 mg tablets - film-coated tablet - lopinavir usp 200 mg ritonavir usp 50 mg - antivirals for systemic use: combinations of